Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance

Launched by PEKING UNIVERSITY AEROSPACE CENTER HOSPITAL · Dec 20, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment option for women with a condition called adenomyosis, which can cause symptoms like heavy bleeding, pain during periods, and an enlarged uterus. The researchers want to see if a technique called microwave ablation, combined with a special method to protect the uterus, is safe and effective for treating this condition. The trial is not yet recruiting participants, but they are planning to involve women between the ages of 18 and 75 who have been diagnosed with adenomyosis and experience related symptoms.

To be eligible for the trial, women must have a confirmed diagnosis of adenomyosis and be willing to undergo the microwave ablation procedure. However, those who are pregnant, have certain serious health issues, or have allergies to anesthesia will not be able to participate. If you join the study, you can expect to undergo the microwave ablation procedure and be monitored for its effects on your symptoms. This research could help improve treatment options for women suffering from adenomyosis in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. UFs or AM diagnosed by pathology and ultrasound；
• • 2. Relevant symptoms such asabnormal uterine bleeding, secondary anemia, progressive dysmenorrhea and enlargement of the uterus；
• • 3. Voluntarily undergo MWA；
• • 4. a confirmed available safe transabdominal puncture path；
• Exclusion Criteria:
• • 1. Pregnancy or malignancy；
• • 2. Severe and uncorrectable coagulation disorders；
• • 3. Severe cardiac, liver, and renal dysfunction；
• • 4. Anesthesia allergy.